登录 注册 会员服务 联系我们

A Common Platform for Antibiotic Dereplication and Adjuvant Discovery

  • Published:2017-01 Issue:1 Volume:24 Page:98-109
  • ISSN:2451-9456
  • Container-title:Cell Chemical Biology
  • language:en
  • Short-container-title:Cell Chemical Biology

Author:

Cox Georgina,Sieron Arthur,King Andrew M.,De Pascale Gianfranco,Pawlowski Andrew C.,Koteva Kalinka,Wright Gerard D.

Funder

Canadian Institutes of Health Research

Natural Sciences and Engineering Research Council

Ontario Research Fund

Canada Research Chair

Publisher

Elsevier BV

Subject

Clinical Biochemistry,Drug Discovery,Pharmacology,Molecular Biology,Molecular Medicine,Biochemistry

Reference50 articles.

1. Construction of Escherichia coli K-12 in-frame, single-gene knockout mutants: the Keio collection;Baba;Mol. Syst. Biol.,2006

2. Antibiotic discovery from actinomycetes: will a renaissance follow the decline and fall?;Baltz;SIM News,2005

3. Multidrug evolutionary strategies to reverse antibiotic resistance;Baym;Science,2016

4. Construction and characterization of new cloning vehicles. II. A multipurpose cloning system;Bolivar;Gene,1977

5. Bad bugs, no drugs: no ESKAPE!;Boucher;Am. Clin. Infect. Dis.,2009
同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3